Emmanuel Papadakis

Stock Analyst at Deutsche Bank

(1.86)
# 3,059
Out of 4,869 analysts
41
Total ratings
47.37%
Success rate
0.58%
Average return

Stocks Rated by Emmanuel Papadakis

BioNTech SE
Sep 19, 2024
Maintains: Buy
Price Target: $95$150
Current: $106.53
Upside: +40.81%
Moderna
Aug 6, 2024
Upgrades: Hold
Price Target: $85$80
Current: $25.90
Upside: +208.88%
Grifols
Mar 12, 2024
Downgrades: Sell
Price Target: n/a
Current: $8.77
Upside: -
AstraZeneca
Feb 8, 2024
Downgrades: Hold
Price Target: n/a
Current: $69.95
Upside: -
Alvotech
Mar 7, 2023
Maintains: Hold
Price Target: $8$12
Current: $9.34
Upside: +28.55%
Sanofi
Aug 12, 2022
Upgrades: Hold
Price Target: n/a
Current: $47.86
Upside: -
Novo Nordisk
Mar 16, 2022
Upgrades: Buy
Price Target: n/a
Current: $73.77
Upside: -
CureVac
Oct 22, 2021
Initiates: Hold
Price Target: $35
Current: $5.44
Upside: +543.97%
Novartis AG
Sep 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $115.77
Upside: -
argenx SE
Jul 23, 2021
Initiates: Hold
Price Target: n/a
Current: $542.15
Upside: -
Downgrades: Sell
Price Target: n/a
Current: $38.07
Upside: -